| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8604951 | International Journal of Surgery Open | 2016 | 7 Pages |
Abstract
Our results indicated that strong expression of stromal MCT4 in CRLM was associated with poor prognosis in patients who undergo liver resection for liver-only colorectal metastases. This finding could be furthermore validated in independent studies and MCT4 could be used as a new biomarker in CRLM and creates the possibility of new studies in targeted therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Christos Petrides, Kyriakos Neofytou, Georgios Agrogiannis, Athanasios Petrou, Anastasios Angelou, Nikolaos Kavantzas, Alexandros Papalambros, Evangelos Felekouras, Theodoros Liakakos, Emmanouel Pikoulis,